Sevoflurane preconditioning confers neuroprotection via anti- apoptosis effects

Acta Neurochirurgica, Supplementum

Volumn 121, Issue , 2016, Pages 55-61

  Wang, Hailian ^a,b   Shi, Hong ^c   Yu, Qiong ^a,b   Chen, Jun ^b,d   Zhang, Feng ^b,d   Gao, Yanqin ^b,d  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; PROTEIN BCL 2; PROTEIN P53; SEVOFLURANE; STRESS ACTIVATED PROTEIN KINASE; BCL2 PROTEIN, RAT; BCL2L1 PROTEIN, RAT; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; NEUROPROTECTIVE AGENT; PROTEIN BCL X;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME DEGRADATION; ENZYME INHIBITION; ISCHEMIC PRECONDITIONING; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION; WESTERN BLOTTING; ANIMAL; BRAIN; CEREBRAL ARTERY DISEASE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANESTHETICS, INHALATION; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; BRAIN; FLUORESCENT ANTIBODY TECHNIQUE; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC PRECONDITIONING; MALE; MAP KINASE KINASE 4; METHYL ETHERS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84944449104     PISSN: 00651419     EISSN: 21978395     Source Type: Book Series    
DOI: 10.1007/978-3-319-18497-5_10     Document Type: Chapter

References (37)

1. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC (1997) Isofl urane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 87:361–370
2. Stetler RA, Leak RK, Gan Y, Li P, Zhang F, Hu X et al (2014) Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical signifi cance. Prog Neurobiol 114:58–83
3. Chen F, Qi Z, Luo Y, Hinchliffe T, Ding G, Xia Y et al (2014) Nonpharmaceutical therapies for stroke: mechanisms and clinical implications. Prog Neurobiol 115:246–269
4. Deng J, Lei C, Chen Y, Fang Z, Yang Q, Zhang H et al (2014) Neuroprotective gases – fantasy or reality for clinical use? Prog Neurobiol 115:210–245
5. Anrather J, Hallenbeck J (2013) Biological networks in ischemic tolerance — rethinking the approach to clinical conditioning. Transl Stroke Res 4:114–129
6. Gao X, Zhang H, Steinberg G, Zhao H (2010) The Akt pathway is involved in rapid ischemic tolerance in focal ischemia in rats. Transl Stroke Res 1:202–209
7. Koch S (2013) Moving towards preconditioning for neurological disorders: are we ready for clinical trials? Transl Stroke Res 4:15–18
8. Meller R, Simon R (2013) Tolerance to ischemia—an increasingly complex biology. Transl Stroke Res 4:40–50
9. Seifert H, Pennypacker K (2014) Molecular and cellular immune responses to ischemic brain injury. Transl Stroke Res 5:543–553
10. Kehl F, Payne RS, Roewer N, Schurr A (2004) Sevofl uraneinduced preconditioning of rat brain in vitro and the role of KATP channels. Brain Res 1021:76–81
11. Payne RS, Akca O, Roewer N, Schurr A, Kehl F (2005) Sevofl urane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res 1034:147–152
12. Zuo Z, Wang Y, Huang Y (2006) Isofl urane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur J Pharmacol 542:84–91
13. Bickler PE, Zhan X, Fahlman CS (2005) Isofl urane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology 103:532–539
14. Codaccioni JL, Velly LJ, Moubarik C, Bruder NJ, Pisano PS, Guillet BA (2009) Sevofl urane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology 110:1271–1278
15. Engelhard K, Werner C, Eberspacher E, Pape M, Blobner M, Hutzler P et al (2004) Sevofl urane and propofol infl uence the expression of apoptosis-regulating proteins after cerebral ischaemia and reperfusion in rats. Eur J Anaesthesiol 21:530–537
16. Wise-Faberowski L, Raizada MK, Sumners C (2003) Desfl urane and sevofl urane attenuate oxygen and glucose deprivation-induced neuronal cell death. J Neurosurg Anesthesiol 15:193–199
17. Yang Q, Dong H, Deng J, Wang Q, Ye R, Li X et al (2011) Sevofl urane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth Analg 112:931–937
18. Chen Y, Nie H, Tian L, Tong L, Deng J, Zhang Y et al (2015) Sevofl urane preconditioning-induced neuroprotection is associated with Akt activation via carboxy-terminal modulator protein inhibition. Br J Anaesth 114:327–335
19. Bedirli N, Bagriacik EU, Emmez H, Yilmaz G, Unal Y, Ozkose Z (2012) Sevofl urane and isofl urane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia. J Neurosurg Anesthesiol 24:336–344
20. Graham SH, Chen J (2001) Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 21:99–109
21. Yu Q, Wang H, Chen J, Gao Y, Liang W (2010) Neuroprotections and mechanisms of inhalational anesthetics against brain ischemia. Front Biosci (Elite Ed) 2:1275–1298
22. Zhang F, Yin W, Chen J (2004) Apoptosis in cerebral ischemia: executional and regulatory signaling mechanisms. Neurol Res 26:835–845
23. Liou AK, Clark RS, Henshall DC, Yin XM, Chen J (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 69:103–142
24. Miyashita T, Harigai M, Hanada M, Reed JC (1994) Identifi cation of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131–3135
25. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci 100:1931–1936
26. Zhang F, Wang S, Luo Y, Ji X, Nemoto EM, Chen J (2009) When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5’-monophosphate on cerebral ischemia in rats. J Cereb Blood Flow Metab 29:1022–1034
27. Zhang F, Signore AP, Zhou Z, Wang S, Cao G, Chen J (2006) Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J Neurosci Res 83:1241–1251
28. Yu Q, Chu M, Wang H, Lu S, Gao H, Li P et al (2011) Sevofl urane preconditioning protects blood–brain-barrier against brain ischemia. Front Biosci (Elite Ed) 3:978–88
29. Wang H, Lu S, Yu Q, Liang W, Gao H, Li P et al (2011) Sevofl urane preconditioning confers neuroprotection via anti-infl ammatory effects. Front Biosci (Elite Ed) 3:604–15
30. Ye R, Yang Q, Kong X, Li N, Zhang Y, Han J et al (2012) Sevofl urane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition. Crit Care Med 40:2685–2693
31. Zhang SD, Zhai J, Zhang H, Wan H, Li DZ (2006) Protective effect of isofl urane and sevofl urane on ischemic neurons and expression of Bcl-2 and ICE genes in rat brain. Biomed Environ Sci 19:143–146
32. Pape M, Engelhard K, Eberspacher E, Hollweck R, Kellermann K, Zintner S et al (2006) The long-term effect of sevofl urane on neuronal cell damage and expression of apoptotic factors after cerebral ischemia and reperfusion in rats. Anesth Analg 103:173–9, table of contents
33. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA et al (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799–1805
34. Kamada H, Nito C, Endo H, Chan PH (2007) Bad as a converging signaling molecule between survival PI3-K/Akt and death JNK in neurons after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 27:521–533
35. Cerezo-Guisado MI, Alvarez-Barrientos A, Argent R, Garcia- Marin LJ, Bragado MJ, Lorenzo MJ (2007) c-Jun N-terminal protein kinase signalling pathway mediates lovastatin-induced rat brain neuroblast apoptosis. Biochim Biophys Acta 1771:164–176
36. Eilers A, Whitfi eld J, Vekrellis K, Neame SJ, Shah B, Ham J (1999) c-Jun and Bax: regulators of programmed cell death in developing neurons. Biochem Soc Trans 27:790–797
37. Hong MY, Gao JL, Cui JZ, Wang KJ, Tian YX, Li R et al (2012) Effect of c-Jun NH(2)-terminal kinase-mediated p53 expression on neuron autophagy following traumatic brain injury in rats. Chin Med J (Engl) 125:2019–2024